Advertisement
Advertisement
LNSR
LENSAR, Inc. Common Stock
5.45
USDSponsored
-0.05
-0.91%
Nov 06, 15:59 UTC -5
Closed
After-Market
5.44
-0.01
-0.18%
LENSAR, Inc. Common Stock (LNSR) Earnings
LNSR Earnings Reports
Positive Surprise Ratio
LNSR beat 10 of 23 last estimates.
43%
Next Report
Next Week
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$14.48M
/-$0.13
Implied change from Q2 26 (Revenue/ EPS)
-12.19%
/-230.00%
Implied change from Q3 25 (Revenue/ EPS)
+1.17%
/-58.06%
LENSAR, Inc. Common Stock earnings per share and revenue
On Aug 13, 2026, LNSR reported earnings of 0.10 USD per share (EPS) for Q2 26, beating the estimate of -0.16 USD, resulting in a 159.42% surprise. Revenue reached 16.50 million, compared to an expected 14.94 million, with a 10.39% difference. The market reacted with a +31.48% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.13 USD, with revenue projected to reach 14.48 million USD, implying an decrease of -230.00% EPS, and decrease of -12.19% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
GLOBUS MEDICAL INC
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.22
Actual
$1.23
Surprise
+0.75%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
CVRx, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.52
Surprise
-2.91%
FAQ
What were LENSAR, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, LENSAR, Inc. Common Stock reported EPS of $0.10, beating estimates by 159.42%, and revenue of $16.50M, 10.39% above expectations.
How did the market react to LENSAR, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 31.48%, changed from $6.29 before the earnings release to $8.27 the day after.
When is LENSAR, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for LENSAR, Inc. Common Stock's next earnings report?
Based on 3
analysts, LENSAR, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of $14.48M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.